SCHEMBL25498024

SCHEMBL25498024

Cc1[nH]c2ccc(Cl)cc2c1C(C)C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT1 Q96EB6 1/20 0.55
LMNA P02545 1/20 0.50
HTR6 P50406 4/20 0.49
HTR7 P34969 2/20 0.49
ADRA2A P08913 1/20 0.49
ADRA2B P18089 1/20 0.49
ADRA2C P18825 1/20 0.49
HTR2B P41595 1/20 0.49
CYP1A2 P05177 1/20 0.49
GAA P10253 1/20 0.49
HPGD P15428 1/20 0.49
PTGS2 P35354 2/20 0.46
MAPT P10636 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ABCC4 O15439 1/20 0.46
C5 P01031 1/20 0.46
PTGS1 P23219 1/20 0.46
PDE4D Q08499 1/20 0.46
CCNB2 O95067 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21095529 0.83 HTR6 (0.48) SIRT1LMNAHTR6HTR7ADRA2A
SCHEMBL20704297 0.81 SIRT1 (0.54) SIRT1LMNAHTR6HTR7ADRA2A
SCHEMBL23502011 0.79 KIF11 (0.53) LMNAHTR6HTR7GAAMAPT
SCHEMBL24063528 0.79 SIRT1 (0.55) SIRT1LMNAHTR6HTR7HPGD
SCHEMBL30547019 0.77 LMNA (0.56) SIRT1LMNAHTR6HTR7ADRA2A
SCHEMBL9843379 0.77 LMNA (0.56) SIRT1LMNAHTR6HTR7ADRA2A
SCHEMBL14019351 0.76 ALDH1A1 (0.65) HTR6HTR7HPGDMAPTMEN1
SCHEMBL29453525 0.76 CHUK (0.64) LMNACYP1A2GAAHPGDPTGS2
SCHEMBL607827 0.76 CHUK (0.64) LMNACYP1A2GAAHPGDPTGS2
SCHEMBL21980641 0.76 LMNA (0.55) SIRT1LMNAHTR6HTR7ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230142654-A1 NOVEL COMPOUND, PREPARATION METHOD THEREOF, AND USE THEREOF PIMEDBIO, INC. (KR) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230142654-A1 NOVEL COMPOUND, PREPARATION METHOD THEREOF, AND USE THEREOF TYR, TYRO3, TH SIRT1 4454/4885LMNA 4574/4885HTR6 1503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.